C-reactive protein levels and risk of mortality from cardiovascular disease in Japanese: The JACC Study

被引:59
|
作者
Iso, Hiroyasu [1 ]
Cui, Renzhe [1 ]
Date, Chigusa [2 ]
Kikuchi, Shogo [3 ]
Tamakoshi, Akiko [3 ]
机构
[1] Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Suita, Osaka 5650871, Japan
[2] Nara Womens Univ, Fac Human Life & Environm, Dept Food Sci & Nutr, Nara 630, Japan
[3] Aichi Med Univ, Sch Med, Dept Publ Hlth, Nagakute, Aichi 48011, Japan
关键词
C-reactive protein; Mortality; Stroke; Coronary heart disease; Cardiovascular disease; Follow-up studies; CORONARY-HEART-DISEASE; GENERAL-POPULATION; SERUM; STROKE; ASSOCIATION; INFLAMMATION; EVENTS; HISAYAMA; RECORDS; DEATHS;
D O I
10.1016/j.atherosclerosis.2009.04.020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objects: Limited evidence of association between C-reactive protein levels and cardiovascular disease has been produced for Japanese whose median protein levels are low by western standards. Methods: We conducted a nested case-control study as part of the Japan Collaborative Cohort Study for evaluation of cancer risk (JACC Study). A total of 39,242 subjects 40-79 years of age provided serum samples at baseline between 1988 and 1990. During the 13-year follow-up, there were 525 deaths from total strokes (ICD10: I60-I69), 209 coronary heart diseases (I20-I25) and 939 total cardiovascular diseases (I00-I99). The control subjects were matched for sex, age, area of residence and year of serum storage, and analyses were conducted after further adjustment for cardiovascular risk factors. Serum high-sensitivity C-reactive protein (hs-CRP) levels were measured with ultra-sensitive latex-enhanced immunoassay. Results: Median hs-CRP levels for controls were 0.40 mg/L for men and 0.41 mg/L for women. Hs-CRP levels were positively associated with risks of mortality from stroke, coronary heart disease, and total cardiovascular disease for men. The respective multivariable odds ratios ( OR 95% CI) for the highest (>= 0.85 mg/L) vs. lowest (< 0.19 mg/L) quartiles of hs-CRP for men were 1.60 (0.90-2.85), 3.68 (1.02-13.3), and 2.31 (1.49-3.59). For women, positive associations with hs-CRP levels were weaker, reaching statistical significance only for total cardiovascular disease: OR = 1.69 (1.06-2.68). The positive association with total cardiovascular disease did not vary according to sex, age, smoking status, or body mass index. Conclusions: Higher serum hs-CRP levels were associated with higher mortality from cardiovascular disease in Japanese. (C) 2009 Published by Elsevier Ireland Ltd.
引用
收藏
页码:291 / 297
页数:7
相关论文
共 50 条
  • [21] C-reactive protein is related to future cognitive impairment and decline in elderly individuals with cardiovascular disease
    Weinstein, Galit
    Lutski, Miriam
    Goldbourt, Uri
    Tanne, David
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2017, 69 : 31 - 37
  • [22] C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis
    Erre, Gian Luca
    Cacciapaglia, Fabio
    Sakellariou, Garifallia
    Manfredi, Andreina
    Bartoloni, Elena
    Viapiana, Ombretta
    Fornaro, Marco
    Cauli, Alberto
    Mangoni, Arduino Aleksander
    Woodman, Richard John
    Palermo, Bianca Lucia
    Gremese, Elisa
    Cafaro, Giacomo
    Nucera, Valeria
    Vacchi, Caterina
    Spinelli, Francesca Romana
    Atzeni, Fabiola
    Piga, Matteo
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 104 : 49 - 54
  • [23] High Sensitivity C-reactive Protein and Cardiovascular Risk Prediction
    Trpkovic, Andreja
    Stanimirovic, Julijana
    Resanovic, Ivana
    Otasevic, Petar
    Jevremovic, Danimir
    Djordje, Radak
    Isenovic, Esma R.
    CURRENT PHARMACEUTICAL ANALYSIS, 2015, 11 (01) : 60 - 65
  • [24] Depressive symptoms and levels of C-reactive protein
    Pikhart, Hynek
    Hubacek, Jaroslav A.
    Kubinova, Ruzena
    Nicholson, Amanda
    Peasey, Anne
    Capkova, Nada
    Poledne, Rudolf
    Bobak, Martin
    SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 2009, 44 (03) : 217 - 222
  • [25] Fiber's impact on high-sensitivity C-reactive protein levels in cardiovascular disease
    Butcher, Jennifer L.
    Beckstrand, Renea L.
    JOURNAL OF THE AMERICAN ACADEMY OF NURSE PRACTITIONERS, 2010, 22 (11): : 566 - 572
  • [26] Cellular growth factors in relation to mortality from cardiovascular disease in middle-aged Japanese: The JACC study
    Iso, Hiroyasu
    Maruyama, Koutatsu
    Ikehara, Satoyo
    Yamagishi, Kazumasa
    Tamakoshi, Akiko
    ATHEROSCLEROSIS, 2012, 224 (01) : 154 - 160
  • [27] Comparison of high sensitive C-reactive protein levels with other biomarkers in cardiovascular disease risk assessment
    Gecgel, Sanem Karadag
    Huysal, Kagan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (04): : 4339 - 4346
  • [28] C-reactive protein levels in patients at cardiovascular risk: EURIKA study
    Julian PJ Halcox
    Carine Roy
    Florence Tubach
    José R Banegas
    Jean Dallongeville
    Guy De Backer
    Eliseo Guallar
    Ogün Sazova
    Jesús Medina
    Joep Perk
    Philippe Gabriel Steg
    Fernando Rodríguez-Artalejo
    Claudio Borghi
    BMC Cardiovascular Disorders, 14
  • [29] Fruit, vegetable and bean intake and mortality from cardiovascular disease among Japanese men and women: the JACC Study
    Nagura, Junko
    Iso, Hiroyasu
    Watanabe, Yoshiyuki
    Maruyama, Koutatsu
    Date, Chigusa
    Toyoshima, Hideaki
    Yamamoto, Akio
    Kikuchi, Shogo
    Koizumi, Akio
    Kondo, Takaaki
    Wada, Yasuhiko
    Inaba, Yutaka
    Tamakoshi, Akiko
    BRITISH JOURNAL OF NUTRITION, 2009, 102 (02) : 285 - 292
  • [30] Serum High-Sensitivity C-Reactive Protein Levels and the Risk of Atrial Fibrillation in Japanese Population: the Circulatory Risk in Communities Study
    Tanaka, Mari
    Imano, Hironori
    Kubota, Yasuhiko
    Yamagishi, Kazumasa
    Umesawa, Mitsumasa
    Muraki, Isao
    Cui, Renzhe
    Hayama-Terada, Mina
    Shimizu, Yuji
    Okada, Takeo
    Ohira, Tetsuya
    Sankai, Tomoko
    Tanigawa, Takeshi
    Sato, Shinichi
    Kitamura, Akihiko
    Kiyama, Masahiko
    Iso, Hiroyasu
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2021, 28 (02) : 194 - 202